000 01678 a2200445 4500
005 20250515202803.0
264 0 _c20100503
008 201005s 0 0 eng d
022 _a1872-6844
024 7 _a10.1016/j.eplepsyres.2009.12.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElger, Christian E
245 0 0 _aA 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.
_h[electronic resource]
260 _bEpilepsy research
_cFeb 2010
300 _a255-63 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnalysis of Variance
650 0 4 _aAnticonvulsants
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aEpilepsies, Partial
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIntention to Treat Analysis
650 0 4 _aMiddle Aged
650 0 4 _aPatient Selection
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
650 0 4 _aTriazoles
_xadministration & dosage
700 1 _aStefan, Hermann
700 1 _aMann, Allison
700 1 _aNarurkar, Milind
700 1 _aSun, Yijun
700 1 _aPerdomo, Carlos
773 0 _tEpilepsy research
_gvol. 88
_gno. 2-3
_gp. 255-63
856 4 0 _uhttps://doi.org/10.1016/j.eplepsyres.2009.12.003
_zAvailable from publisher's website
999 _c19439865
_d19439865